Showing posts with label Bristol-Myers. Show all posts
Showing posts with label Bristol-Myers. Show all posts

8/31/10

New Targets, Dual Agonists Increase Possibilities for Treating Diabetes

Action of GLP-1 and DPP-4 inhibitors.Image via Wikipedia Fritz French, Chief Executive Officer, Marcadia Biotech, Carmel, Ind.
Drug Discovery & Development - August 16, 2010


Diabetes is a common chronic disease affecting an estimated 285 million adults worldwide. This number will continue to grow as the population ages and becomes more obese—both risk factors for type 2 diabetes. The diabetes treatment market generated over $25 billion in 2009 and the number of patients is continuously rising.